MFA-011

N/A

Report date: 2025/01/08 15:16:24

Base Information

Drug NameMFA-011

Drug Alias NameMFA011MFA-011

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsInterleukin-15 receptors agonists

TargetsT cell immunoglobulin and ITIM domainsInterleukin-15 receptors

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMediMabBio Inc

China Registration ClassN/A

Develop Information

Active CompaniesMediMabBio Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A